Latest News
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
Nov 7, 2022 MDimune, Inc. announced a business agreement with EUMC and acquisition of IP from EUMC to develop therapeutics for inflammatory bowel diseases (IBD).
MDimune and SensoryCure announce a collaboration to develop therapeutics for hearing loss
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
Oct 24, 2022 MDimune, Inc. enters into an MOU with SensoryCure to collaborate on the development of therapeutics for hearing loss .
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
MDimune acquires IP and partners with Ewha Womans University Medical Center on IBD therapeutics
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
Sep 15, 2022 Caravan Biologix and MDimune announced their collaboration to enhance the effects of chimeric antigen receptor-expressing natural killer (CAR-NK) cells on various solid tumor cancers.
About Us
BioDrone™ Platform Technology
BioDrone™ Platform Technology
BioDrone™ Platform Technology
Groundbreaking drug delivery platform that precisely delivers various drugs to targeted lesions by loading them into cell-derived vesicles (CDVs) derived from human cells.
Business Model
BioDrone™ Platform Technology
BioDrone™ Platform Technology
MDimune is currently seeking partners for R&D collaborations that utilize the BioDrone™ (CDVs) platform for next-generation cell therapies or targeted payload delivery.
Open Innovation
BioDrone™ Platform Technology
Open Innovation
Platform Inside Development Outside (PIDO) model to collaborate with pharma/biotech partners in diverse therapeutic areas (cancer, rare diseases, CNS disorders, etc.).